PoliticalRepoPoliticalRepo

United States · Bill · S

S. 946 (108th)

Drug Competition Act of 2003

referredUnited States· United States Congress· EN

Introduced

29 April 2003

Last action

29 April 2003 · Introduced

Status

Read twice and referred to the Committee on the Judiciary.

Sponsors

Sen. Leahy, Patrick J. [D-VT], Chuck Grassley, Richard Durbin, Sen. Feingold, Russell D. [D-WI], Sen. Kohl, Herb [D-WI], Charles Schumer, Maria Cantwell

Subjects

Discovery layer

Source updated

10 August 2026

Summary

Drug Competition Act of 2003 - Sets filing requirements for a generic drug applicant that has submitted an Abbreviated New Drug Application (ANDA) and a brand name drug company that enter into an agreement, before a drug enters the market, regarding: (1) the manufacture, marketing, or sale of the brand name or the generic drug; or (2) the 180-day semi-exclusivity period referred to in the Federal Food, Drug, and Cosmetic Act as it applies to such ANDA or any other ANDA based on the same brand name drug. Requires each such party to file such agreement and any related agreements with the Assistant Attorney General and the Federal Trade Commission (FTC). Makes an exception for agreements that solely concern purchase orders for raw material supplies, equipment and facility contracts, or employment or consulting contracts. Requires such agreements to be filed not later than ten business days after the date they are executed. Exempts any such information or documentary material filed from disclosure under the Freedom of Information Act. Prohibits such information or material from being made public, except as relevant to any administrative or judicial action or proceeding. Subjects an applicant or company to a civil penalty of up to $11,000 for each day such entity fails to comply with this Act, recoverable in a civil action brought by the United States or the FTC. Authorizes a U.S. district court to order compliance and grant equitable relief.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 29 April 2003

    Introduced

    Read twice and referred to the Committee on the Judiciary.

    Source: IntroReferral

  2. 29 April 2003

    Introduced

    Sponsor introductory remarks on measure. (CR S5493-5494)

    Source: IntroReferral

  3. 29 April 2003

    Introduced

    Introduced in Senate

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in Senate (text)

View fileDownload file

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.